PPARgamma is essential for protection against nonalcoholic steatohepatitis.
about
Obesity and cancer progression: is there a role of fatty acid metabolism?Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis.RORα decreases oxidative stress through the induction of SOD2 and GPx1 expression and thereby protects against nonalcoholic steatohepatitis in mice.ChIP-seq in steatohepatitis and normal liver tissue identifies candidate disease mechanisms related to progression to cancer.Effect of Chronic Pioglitazone Treatment on Hepatic Gene Expression Profile in Obese C57BL/6J Mice.Protein and folic acid content in the maternal diet determine lipid metabolism and response to high-fat feeding in rat progeny in an age-dependent mannerGenistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPARγ in a Rat Model.Early maternal undernutrition programs increased feed intake, altered glucose metabolism and insulin secretion, and liver function in aged female offspring.Environmental toxin-linked nonalcoholic steatohepatitis and hepatic metabolic reprogramming in obese mice.PPARs and Mitochondrial Metabolism: From NAFLD to HCC.Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas.Pathophysiology of NASH: perspectives for a targeted treatment.Effects and Potential Mechanisms of Pioglitazone on Lipid Metabolism in Obese Diabetic KKAy Mice.Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice.Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.Intervening TNF-α via PPARγ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease.Comparison between the efficacies of curcumin and puerarin in C57BL/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet.Platyconic acid, a saponin from Platycodi radix, improves glucose homeostasis by enhancing insulin sensitivity in vitro and in vivo.PPAR-γ agonist ameliorates liver pathology accompanied by increasing regulatory B and T cells in high-fat-diet mice.The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis.Glucagon like-peptide 1 receptor and the liver
P2860
Q28081152-8EB9C7FA-C49C-427C-B2AC-BEB9044C0EBCQ30697447-67C472BA-C7B3-4A42-9C93-0BE6DC4D7074Q34431785-96E9C5F0-123D-43DD-934D-EF1F7501DB61Q35037365-E8E81B93-E70E-4D60-9A52-6087A6958B90Q35813795-62ABF613-C725-4CBF-988D-30621B2215BCQ35863353-74529E90-B8AD-4786-891C-E748F2E274E0Q35890416-32ED3147-F111-462D-9408-5856D7699584Q35900851-5A57D8B5-54F1-414F-979B-ED93DB0A1F65Q37000017-FD68ADDE-19C9-421B-9141-654A5196E38EQ37575571-B8BEE080-F65D-4E7B-A9BF-60930754CEA1Q37691021-ACD595C2-CE81-4161-9914-0582DA604053Q37699476-0E0345C3-E095-4AC8-A331-ED091C3C47B8Q37706430-F495EB63-5DF5-4045-A420-3DA61ABB8527Q38018841-C81D9804-7A93-4903-8BEC-112E77EEDB51Q38466831-A15ED7D6-1A4F-43FC-A78A-6D9765C2A398Q39326587-50D3C757-81DE-48FE-A3BF-D83D38FF684EQ40263666-C2F37A78-FC3C-4CB7-928C-382B9CE5E3F1Q40683672-69E07E71-8FBA-4942-8E50-83F66F9DB35AQ41942220-3E0FAEC9-C72C-44AD-9674-047BCEC8E018Q42806768-3E545612-CE57-4512-9C19-9554BEF3F840Q51157271-44D79127-AA04-4AF8-8424-9D587C46825CQ52699074-DDF6ADC6-60D1-4CDC-A14C-F884A8DA45EBQ58447971-421414A7-8927-482B-B566-E871714A17E5
P2860
PPARgamma is essential for protection against nonalcoholic steatohepatitis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
PPARgamma is essential for protection against nonalcoholic steatohepatitis.
@en
PPARgamma is essential for protection against nonalcoholic steatohepatitis.
@nl
type
label
PPARgamma is essential for protection against nonalcoholic steatohepatitis.
@en
PPARgamma is essential for protection against nonalcoholic steatohepatitis.
@nl
prefLabel
PPARgamma is essential for protection against nonalcoholic steatohepatitis.
@en
PPARgamma is essential for protection against nonalcoholic steatohepatitis.
@nl
P2093
P2860
P356
P1433
P1476
PPARgamma is essential for protection against nonalcoholic steatohepatitis
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2010.41
P577
2010-04-08T00:00:00Z
P5875
P6179
1043306456